Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Price / sales

Price / sales at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
2.6×+0.8×
Alkermes logo
AlkermesALKS
3.8×+0.2×
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
12.2×-1.0×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
60×+58.2×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
1.3×+0.4×
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
3.5×+0.7×

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.

market cap/total revenue=1.8×

Based on the most recent quarter.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s price / sales?
Harmony Biosciences Holdings, Inc. (HRMY) reported price / sales of 1.8× in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s price / sales changed year-over-year?
Harmony Biosciences Holdings, Inc.'s price / sales decreased by 29.5% year-over-year, from 2.6× to 1.8×.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s price / sales?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s price / sales has grown at a -28.1% compound annual growth rate (CAGR), from 12.9× to 2.5×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.